The Cooper Companies (COO) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended January 2026, The Cooper Companies (COO) reported revenue of $1.02 billion, up 6.2% over the same period last year. EPS came in at $1.10, compared to $0.92 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.03 billion, representing a surprise of -0.13%. The company delivered an EPS surprise of +7.06%, with the consensus EPS estimate being $1.03.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue by Geography- Americas: $289 million versus $289.77 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.7% change.
• Revenue by Geography- Asia Pacific: $123.8 million compared to the $136.81 million average estimate based on three analysts. The reported number represents a change of -3.8% year over year.
• Revenue by Geography- EMEA: $282.3 million versus $269.49 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +14.5% change.
• Revenue by Category- CVI: $695.1 million compared to the $696.35 million average estimate based on six analysts. The reported number represents a change of +7.6% year over year.
• Revenue by Category- CSI: $329 million versus the six-analyst average estimate of $328.85 million. The reported number represents a year-over-year change of +3.3%.
• Revenue by Category- CSI- Office and surgical: $202.4 million versus the five-analyst average estimate of $204.86 million. The reported number represents a year-over-year change of +1.8%.
• Revenue by Category- CSI- Fertility: $126.6 million versus the five-analyst average estimate of $123.72 million. The reported number represents a year-over-year change of +5.8%.
• Revenue by Category- CVI- Sphere, other: $343.9 million versus $348.27 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +5.3% change.
• Revenue by Category- CVI- Toric and multifocal: $351.2 million compared to the $348.7 million average estimate based on five analysts. The reported number represents a change of +10% year over year.

View all Key Company Metrics for The Cooper Companies here>>>

Shares of The Cooper Companies have returned +1.3% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
The Cooper Companies, Inc. (COO): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research